Alkeran and mucosal inflammation 
Alkeran and mucosal inflammation Patient Reports February 11, 2012
Alkeran Side Effects Report #5145417-5
Alkeran side effect was reported by a Consumer or non-health professional from NETHERLANDS on Oct 19, 2006. Female patient, child 9 years of age, was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, convulsion, encephalopathy, hepatotoxicity, mucosal inflammation. Alkeran dosage: 140 MG/M2 / CYCLIC. During the same period patient was treated with MYLERAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CLONAZEPAM. Patient recovered.
Alkeran Side Effects Report #5819196-X
Alkeran side effect was reported by a Physician from THAILAND on July 16, 2008. Female patient, 56 years of age, was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: bone marrow failure, mucosal inflammation, nausea
. Alkeran dosage: 100MG PER DAY. Patient died.Alkeran Side Effects Report #5819194-6
Alkeran side effect was reported by a Physician from THAILAND on July 16, 2008. Male patient, 48 years of age, was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: bone marrow failure, mucosal inflammation, nausea
. Alkeran dosage: 300MG PER DAY. Patient recovered.Alkeran Side Effects Report #5145431-X
Alkeran side effect was reported by a Health Professional from NETHERLANDS on Oct 19, 2006. Male patient, 16 years of age, was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, mucosal inflammation, multi-organ failure, sepsis
, venoocclusive disease. Alkeran dosage: 140 MG/M2/CYCLIC. During the same period patient was treated with MYLERAN, CYCLOPHOSPHAMIDE, CAMPATH, CLONAZEPAM. Patient died.Alkeran Side Effects Report #5034755-2
Alkeran side effect was reported by a Physician from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.
Alkeran Side Effects Report #5034757-6
Alkeran side effect was reported by a Physician from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in intestine, graft versus host disease in skin, hepatotoxicity, mucosal inflammation. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #5034758-8
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, mucosal inflammation, platelet count decreased, sepsis
. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.Alkeran Side Effects Report #5034759-X
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: aplasia, graft versus host disease, graft versus host disease in skin, mucosal inflammation, platelet count decreased. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #5034760-6
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: aplasia, graft versus host disease, graft versus host disease in skin, mucosal inflammation, platelet count decreased. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #5034762-X
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in intestine, graft versus host disease in skin, mucosal inflammation, pneumonia aspergillus. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #5035021-1
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease in intestine, graft versus host disease in skin, hepatotoxicity, mucosal inflammation, nephropathy toxic, pneumonia
. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.Alkeran Side Effects Report #5035027-2
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: mucosal inflammation, pneumonia aspergillus. Alkeran dosage: 150MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.
Alkeran Side Effects Report #5035042-9
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, hepatotoxicity, leukaemia recurrent, mucosal inflammation, pneumonia
, stem cell transplant, surgical procedure repeated. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.Alkeran Side Effects Report #5035044-2
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.
Alkeran Side Effects Report #5035047-8
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in intestine, graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.
Alkeran Side Effects Report #5035050-8
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #5035053-3
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: diarrhoea, graft versus host disease, mucosal inflammation, pneumonia aspergillus. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.
Alkeran Side Effects Report #5035056-9
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, graft versus host disease in liver, graft versus host disease in skin, infection
, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.Alkeran Side Effects Report #5035060-0
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: hepatotoxicity, mucosal inflammation, pneumonia aspergillus. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #5035063-6
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #4799952-X
Alkeran side effect was reported by a Consumer or non-health professional from ITALY on Sept 29, 2005. Male patient, 36 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Alkeran. After drug was administered, patient experienced the following side effects: herpes simplex
, mucosal inflammation, pyrexia, transaminases increased. Alkeran dosage: 140 MG/M2 CYCLIC. During the same period patient was treated with CARMUSTINE, CYTARABINE, ETOPOSIDE, QUINOLONE, ACYCLOVIR, GRANULOCYTE COL, ZIDOVUDINE. Patient recovered.Alkeran Side Effects Report #6059017-6
Alkeran side effect was reported by a Consumer or non-health professional from FRANCE on Jan 19, 2009. Female patient, child 4 years of age, weighting 36.16 lb, was diagnosed with neuroblastoma
and was treated with Alkeran. After drug was administered, patient experienced the following side effects: blood creatinine increased, candidiasis, face oedema, folliculitis, hyponatraemia, mucosal inflammation, oral herpes, overdose, skin erosion. Alkeran dosage: 45MG CYCLIC. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.Alkeran Side Effects Report #6115051-9
Alkeran side effect was reported by a Consumer or non-health professional from FRANCE on Mar 04, 2009. Female patient, child 4 years of age, weighting 36.16 lb, was diagnosed with neuroblastoma
and was treated with Alkeran. After drug was administered, patient experienced the following side effects: blood creatinine increased, candidiasis, face oedema, folliculitis, hyponatraemia, mucosal inflammation, oral herpes, overdose, skin erosion. Alkeran dosage: 45MG CYCLIC. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.Alkeran Side Effects Report #5709650-3
Alkeran side effect was reported by a Consumer or non-health professional from FRANCE on Apr 14, 2008. Female patient, child 1 years of age, weighting 36.16 lb, was diagnosed with neuroblastoma
and was treated with Alkeran. After drug was administered, patient experienced the following side effects: candidiasis, folliculitis, mucosal inflammation, oral herpes, skin erosion, skin exfoliation, skin hyperpigmentation. Alkeran dosage: 45MG CYCLIC. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.Alkeran Side Effects Report #5740629-1
Alkeran side effect was reported by a Consumer or non-health professional from FRANCE on May 06, 2008. Female patient, child 1 years of age, weighting 36.16 lb, was diagnosed with neuroblastoma
and was treated with Alkeran. After drug was administered, patient experienced the following side effects: candidiasis, folliculitis, mucosal inflammation, oral herpes, skin erosion, skin exfoliation, skin hyperpigmentation, toxic skin eruption. Alkeran dosage: 45MG CYCLIC. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.Alkeran Side Effects Report #4587650-7
Alkeran side effect was reported by a Health Professional from on Jan 26, 2005. Male patient, 47 years of age, was diagnosed with nephroblastoma and was treated with Alkeran. After drug was administered, patient experienced the following side effects: febrile neutropenia, hyperbilirubinaemia, mucosal inflammation, renal failure acute. Alkeran dosage: 60 MG/M2. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE, STEM CELL TRANSPLANT. Patient recovered.
Alkeran Side Effects Report #4686964-X
Alkeran side effect was reported by a Consumer or non-health professional from on May 23, 2005. Male patient, 60 years of age, was diagnosed with multiple myeloma
and was treated with Alkeran. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematemesis, haemodialysis, melaena, mucosal inflammation, multi-organ failure, pneumonia , polyneuropathy. Alkeran dosage: 200 MG/M2 / INTRVENOUS. During the same period patient was treated with FILGRASTIM, CYCLOPHOSPHAMIDE, CIPROFLOXACIN, ACYCLOVIR, NYSTATIN, SULPHAMETHOXAZOLE, INTERFERON ALFA. Patient died.Alkeran Side Effects Report #5816222-9
Alkeran side effect was reported by a Physician from THAILAND on July 16, 2008. Male patient, 54 years of age, was diagnosed with multiple myeloma
and was treated with Alkeran. After drug was administered, patient experienced the following side effects: febrile neutropenia, mucosal inflammation. Alkeran dosage: 340MG PER DAY. Patient was hospitalized. Patient recovered.Alkeran Side Effects Report #5819193-4
Alkeran side effect was reported by a Physician from THAILAND on July 16, 2008. Female patient, 49 years of age, was diagnosed with multiple myeloma
and was treated with Alkeran. After drug was administered, patient experienced the following side effects: diarrhoea, mucosal inflammation, neutropenia. Alkeran dosage: 300MG PER DAY. Patient was hospitalized. Patient recovered.Alkeran Side Effects Report #6068705-7
Alkeran side effect was reported by a Consumer or non-health professional from JAPAN on Jan 30, 2009. Male patient, child 8 years of age, was diagnosed with bone marrow transplant
, prophylaxis against graft versus host disease and was treated with Alkeran. After drug was administered, patient experienced the following side effects: diarrhoea, liver disorder, mucosal inflammation. Alkeran dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, TACROLIMUS HYDRATE, METHOTREXATE. Patient recovered.Alkeran Side Effects Report #6079176-9
Alkeran side effect was reported by a Consumer or non-health professional from JAPAN on Feb 13, 2009. Male patient, child 8 years of age, was diagnosed with bone marrow transplant
, prophylaxis against graft versus host disease and was treated with Alkeran. After drug was administered, patient experienced the following side effects: diarrhoea, liver disorder, mucosal inflammation. Alkeran dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, TACROLIMUS HYDRATE, METHOTREXATE. Patient was hospitalized. Patient recovered.Alkeran Side Effects Report #6013751-2
Alkeran side effect was reported by a Consumer or non-health professional from FRANCE on Dec 10, 2008. Female patient, weighting 24.25 lb, was diagnosed with bone marrow transplant
and was treated with Alkeran. After drug was administered, patient experienced the following side effects: hepatocellular injury, hepatomegaly, mucosal inflammation, oedema peripheral, venoocclusive liver disease, weight increased. Alkeran dosage: 70MG SINGLE DOSE. During the same period patient was treated with BUSULPHAN. Patient was hospitalized. Patient recovered.Alkeran Side Effects Report #4974014-7
Alkeran side effect was reported by a Consumer or non-health professional from AUSTRIA on Mar 27, 2006. Male patient, 59 years of age, was diagnosed with amyloidosis and was treated with Alkeran. After drug was administered, patient experienced the following side effects: diarrhoea, haemodialysis, mucosal inflammation, nausea
, post procedural complication, renal failure acute. Alkeran dosage: 200 MG/M2/. During the same period patient was treated with STEM CELL TRANSPLANT. Patient recovered.Alkeran Side Effects Report #4974017-2
Alkeran side effect was reported by a Consumer or non-health professional from AUSTRIA on Mar 27, 2006. Male patient, 51 years of age, was diagnosed with amyloidosis and was treated with Alkeran. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, haemodialysis, mucosal inflammation, nausea
, renal failure acute, renal transplant, splenic rupture. Alkeran dosage: 200 MG/M2. During the same period patient was treated with STEM CELL TRANSPLANT. Patient recovered.Alkeran Side Effects Report #4974016-0
Alkeran side effect was reported by a Consumer or non-health professional from AUSTRIA on Mar 27, 2006. Male patient, 43 years of age, was diagnosed with amyloidosis and was treated with Alkeran. After drug was administered, patient experienced the following side effects: diarrhoea, mucosal inflammation, nausea
, neutropenia, pyrexia, renal failure acute, stem cell transplant. Alkeran dosage: 200 MG/M2. During the same period patient was treated with STEM CELL TRANSPLANT. Patient recovered.Alkeran Side Effects Report #4974018-4
Alkeran side effect was reported by a Consumer or non-health professional from AUSTRIA on Mar 27, 2006. Female patient was diagnosed with amyloidosis and was treated with Alkeran. After drug was administered, patient experienced the following side effects: complications of transplant surgery, diarrhoea, febrile neutropenia, gastrointestinal haemorrhage, gastrointestinal perforation, haemodialysis, mucosal inflammation, nausea
, nephrotic syndrome. Alkeran dosage: 200 MG/M2. During the same period patient was treated with STEM CELL TRANSPLANT. Patient died.Alkeran Side Effects Report #4956717-3
Alkeran side effect was reported by a Physician from JAPAN on Mar 22, 2006. Male patient, child 9 years of age, weighting 52.91 lb, was treated with Alkeran. After drug was administered, patient experienced the following side effects: mucosal inflammation, nausea
, odynophagia, stomatitis. Alkeran dosage: unknown. During the same period patient was treated with BUSULFAN, NEUTROGIN, CYCLOSPORINE, METHOTREXATE, IMMUNE GLOBULIN INTRAVENOUS, ZOVIRAX, DEPAKENE. Patient recovered.Alkeran Side Effects Report #5008089-6
Alkeran side effect was reported by a Physician from JAPAN on May 04, 2006. Male patient, 65 years of age, was treated with Alkeran. After drug was administered, patient experienced the following side effects: blood test abnormal, cardiotoxicity, febrile neutropenia, gastrointestinal toxicity, hepatotoxicity, marrow hyperplasia, mucosal inflammation, multi-organ failure. Alkeran dosage: 80 MG/M2 /CYCLIC. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, DIURETIC. Patient died.
Alkeran Side Effects Report #5211989-5
Alkeran side effect was reported by a Consumer or non-health professional from FRANCE on Jan 08, 2007. Female patient, 59 years of age, weighting 130.1 lb, was treated with Alkeran. After drug was administered, patient experienced the following side effects: mucosal inflammation, pneumonia respiratory syncytial viral, renal failure, renal failure acute. Alkeran dosage: unknown. During the same period patient was treated with ARACYTINE, ETOPOSIDE, BICNU, PAROXETINE, BACTRIM, SPECIAFOLDINE, ZOLPIDEM TARTRATE, DIFFU K. Patient was hospitalized. Patient recovered.
Alkeran Side Effects Report #5220893-8
Alkeran side effect was reported by a Consumer or non-health professional from FRANCE on Jan 17, 2007. Female patient, 59 years of age, weighting 130.1 lb, was diagnosed with prophylaxis and was treated with Alkeran. After drug was administered, patient experienced the following side effects: mucosal inflammation, pneumonia respiratory syncytial viral, renal failure, renal failure acute. Alkeran dosage: unknown. During the same period patient was treated with ARACYTINE, ETOPOSIDE, BICNU, KEPIVANCE, PAROXETINE, BACTRIM, SPECIAFOLDINE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.
Alkeran Side Effects Report #5819195-8
Alkeran side effect was reported by a Physician from THAILAND on July 16, 2008. Female patient, 49 years of age, was treated with Alkeran. After drug was administered, patient experienced the following side effects: bone marrow failure, mucosal inflammation, nausea
. Alkeran dosage: 100MG PER DAY. Patient recovered.Alkeran Side Effects Report #5035635-9
Alkeran side effect was reported by a Consumer or non-health professional from FRANCE on June 20, 2006. Male patient, 44 years of age, was treated with Alkeran. After drug was administered, patient experienced the following side effects: aplasia, blood alkaline phosphatase increased, blood phosphorus increased, gamma-glutamyltransferase increased, incorrect dose administered, mucosal inflammation, neutrophil count decreased, platelet count decreased, transaminases increased. Alkeran dosage: 255MG PER DAY. During the same period patient was treated with BUSULFAN. Patient was hospitalized. Patient recovered.
Alkeran Side Effects Report #5040415-4
Alkeran side effect was reported by a Consumer or non-health professional from FRANCE on June 20, 2006. Male patient, 44 years of age, was treated with Alkeran. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, bone marrow failure, gamma-glutamyltransferase increased, mucosal inflammation, transaminases increased. Alkeran dosage: 255MG PER DAY. During the same period patient was treated with BUSULFAN. Patient was hospitalized. Patient recovered.